NIH Genome Sequencing Program Targets Genomic Bases of Common, Rare Disease
The National Institutes of Health will fund a set of genome sequencing and analysis centers whose research will focus on understanding the genomic bases of common and rare human diseases. The National Human Genome Research Institute (NHGRI), part of NIH, today launched the Centers for Common Disease Genomics (CCDG), which will use genome sequencing to explore the genomic contributions to common diseases such as heart disease, diabetes, stroke and autism. NHGRI also announced the next phase of a complementary program, the Centers for Mendelian Genomics (CMG), which will continue investigating the genomic underpinnings of rare, typically inherited diseases, such as cystic fibrosis and muscular dystrophy.
- Media Availability: NHGRI Celebrates Na
- [caption id="attachment_1447" align="alignleft" width="150"] NIH Scientists Discover Genetic Cause o
- [caption id="attachment_1199" align="alignleft" width="150"] NIH Researchers Discover Otulipenia[/ca
- [caption id="attachment_1196" align="alignleft" width="150"] Genetics of Type 2 Diabetes G